The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 42
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte NASSIM USMAN,
ROBERT J. CEDERGREN,
JEAN-PIERRE PERREAULT,
JING-HUA YANG, and
ALEXANDER RICH
__________
Appeal No. 2002-1251
Application No. 08/459,340
__________
HEARD October 7, 2002
__________
Before WINTERS, WILLIAM F. SMITH, and GRIMES, Administrative Patent
Judges.
GRIMES, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on appeal under 35 U.S.C. § 134 from the examiner’s
final rejection of claims 74 and 80-82, all of the claims in the application. Claim
74 is representative and reads as follows:
74. A pharmaceutical composition, comprising:
at least one enzymatic nucleic acid molecule having a
ribonucleotide at a catalytically critical site, at least one
deoxyribonucleotide and at least one nucleic acid analog; and
a pharmaceutically acceptable carrier.
Page: 1 2 3 4 5 6 7 8 9 10 11 12 Next
Last modified: November 3, 2007